Glycated albumin promotes a generalized vasculopathy in the db/db mouse

Biochem Biophys Res Commun. 1996 Jan 5;218(1):72-5. doi: 10.1006/bbrc.1996.0014.


Increased protein glycation has been mechanistically linked to accelerated vascular pathobiology in diabetes. Because glycated albumin induces biosynthetic abnormalities in cultured aortic endothelial cells that resemble those associated with macrovascular disease, we sought evidence that increased glycated albumin is operative in the genesis of diabetic vasculopathy in vivo. Plasma concentrations of fibronectin, a sensitive marker of endothelial cell damage, were increased two-fold in diabetic db/db mice compared with their nondiabetic db/m littermates. Treatment with monoclonal antibodies specifically reactive with albumin modified by Amadori glucose adducts normalized fibronectin in diabetic animals despite persistent hyperglycemia. These findings suggest that increased glycated albumin causally contributes to diabetic vasculopathy, and that blocking this influence ameliorates vascular damage.

Publication types

  • Comparative Study

MeSH terms

  • Aging / physiology
  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Biomarkers / blood
  • Blood Glucose / metabolism
  • Body Weight
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetic Angiopathies / physiopathology*
  • Diabetic Angiopathies / prevention & control
  • Fibronectins / blood*
  • Mice
  • Mice, Mutant Strains
  • Reference Values
  • Serum Albumin / immunology
  • Serum Albumin / toxicity*


  • Antibodies, Monoclonal
  • Biomarkers
  • Blood Glucose
  • Fibronectins
  • Serum Albumin
  • glycosylated serum albumin